Gibraltar: Pharmaceutical products
HS chapter 30 · Chemicals
Pharmaceutical products
Gibraltar pharmaceutical products over time
US$, annual.
In more detail
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$6,000 | 85.7% |
| 3002 Human blood | US$1,000 | 14.3% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$6,000 | 85.7% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$1,000 | 14.3% |
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$22.6 million | 91.3% |
| 3002 Human blood | US$1.2 million | 4.8% |
| 3003 Medicaments | US$374,000 | 1.5% |
| 3006 Pharmaceutical goods | US$363,000 | 1.5% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$219,000 | 0.9% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$18.8 million | 75.9% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$1.1 million | 4.6% |
| 300440 Medicaments: containing alkaloids or their derivatives (but not hormones or antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$917,000 | 3.7% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$890,000 | 3.6% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$803,000 | 3.2% |
| 300410 Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | US$570,000 | 2.3% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$303,000 | 1.2% |
| 300220 Vaccines: for human medicine | US$270,000 | 1.1% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$221,000 | 0.9% |
| 300630 Pharmaceutical goods: opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | US$122,000 | 0.5% |
Shares are of Gibraltar's pharmaceutical products in the same direction. See Pharmaceutical products for all countries or all of Gibraltar's trade.
More Gibraltar products
- 27 Mineral fuels, mineral oils and products of their distillation
- 89 Ships, boats and floating structures
- 87 Vehicles
- 84 Machinery and mechanical appliances, boilers, nuclear reactors
- 85 Electrical machinery and equipment and parts thereof
- 24 Tobacco and manufactured tobacco substitutes
- 71 Natural, cultured pearls
- 90 Optical, photographic, cinematographic, measuring, checking, medical or surgical instruments and apparatus
- 97 Works of art
- 94 Furniture
- 22 Beverages, spirits and vinegar
- 73 Iron or steel articles
Gibraltar pharmaceutical products: questions and answers
How much pharmaceutical products does Gibraltar export?
In 2024, Gibraltar exported US$7,000 of pharmaceutical products (HS chapter 30), 0.0% of its total exports. That ranks it 202 of 213 exporting countries in the data.
What are Gibraltar's biggest pharmaceutical products exports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$6,000), Human blood (3002, US$1,000).
How much pharmaceutical products does Gibraltar import?
In 2024, Gibraltar imported US$24.7 million of pharmaceutical products (HS chapter 30), 0.3% of its total imports. That ranks it 173 of 226 importing countries in the data.
What are Gibraltar's biggest pharmaceutical products imports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$22.6 million), Human blood (3002, US$1.2 million), Medicaments (3003, US$374,000).
